FunPep Company Limited (4881.T)
JPY 131.0
(0.77%)
JPY 131.0
(0.77%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 25.54 Million JPY | -71.11% |
| 2022 | 88.42 Million JPY | 73.69% |
| 2021 | 50.9 Million JPY | 99.62% |
| 2020 | 25.5 Million JPY | -12.88% |
| 2019 | 29.27 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 55.37 Million JPY | 116.8% |
| 2024 Q2 | 40.18 Million JPY | -27.43% |
| 2023 Q2 | 55.18 Million JPY | -37.95% |
| 2023 FY | 25.54 Million JPY | -71.11% |
| 2023 Q3 | 53.73 Million JPY | -2.63% |
| 2023 Q4 | 25.54 Million JPY | -52.47% |
| 2023 Q1 | 88.93 Million JPY | 0.58% |
| 2022 Q3 | 78.61 Million JPY | 0.0% |
| 2022 FY | 88.42 Million JPY | 73.69% |
| 2022 Q4 | 88.42 Million JPY | 12.47% |
| 2021 FY | 50.9 Million JPY | 99.62% |
| 2020 FY | 25.5 Million JPY | -12.88% |
| 2019 FY | - JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 96.261% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -42.456% |
| GNI Group Ltd. | 2.33 Billion JPY | 98.904% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 98.853% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 62.151% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 97.721% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 75.331% |
| AnGes, Inc. | 1.61 Billion JPY | 98.419% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 65.485% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 99.12% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 92.066% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -13780.978% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 81.775% |
| CanBas Co., Ltd. | 728 Thousand JPY | -3408.379% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 70.931% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 82.735% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 60.159% |
| Kidswell Bio Corporation | 875.65 Million JPY | 97.083% |
| PeptiDream Inc. | 2.4 Billion JPY | 98.938% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -378.117% |
| Ribomic Inc. | 2.27 Million JPY | -1023.175% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -2554099900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 29.053% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | 11.928% |
| CellSource Co., Ltd. | 305.92 Million JPY | 91.651% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 92.984% |
| Stella Pharma Corporation | 1.11 Billion JPY | 97.712% |
| TMS Co., Ltd. | 50.02 Million JPY | 48.944% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -22.2% |
| Cuorips Inc. | 1.04 Million JPY | -2348.802% |
| K Pharma,Inc. | 10.79 Million JPY | -136.622% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.784% |
| ReproCELL Incorporated | 248.14 Million JPY | 89.707% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 94.332% |
| StemCell Institute Inc. | 42.26 Million JPY | 39.565% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 88.825% |
| CellSeed Inc. | 46.19 Million JPY | 44.706% |